Drugs / Levodropropizine

Trials 6 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT07161180 Aug → Oct 2025 overdue Pharmbio Korea Co., Ltd. Recruiting No outcome recorded
Phase 1 NCT01573663 Feb → Apr 2012 Hanmi Pharmaceutical Company Limited Completed No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT06252454 Feb → Dec 2024 University Hospital Hradec Kralove Unknown No outcome recorded
Phase 32 trials
Phase 3 NCT03489837 Jan 2017 → Oct 2018 Hyundai Pharm Completed No outcome recorded
Phase 3 NCT03837938 Nov 2016 → Mar 2018 Dompé Farmaceutici S.p.A Completed No outcome recorded
Phase 41 trial
Phase 4 NCT06907355 May → Nov 2025 respiratory tract infectious disorder Pontificia Universidad Catolica de Chile Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01416480 Comparator May 2010 → Feb 2011 bronchitis Ahn-Gook Pharmaceuticals Co.,Ltd Completed No outcome recorded

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 8 sources stand behind the page.

FieldValueCited text
Known as Levodropropizine “Levopront® (levodropropizine) syrup 30 mg/5 ml 10 ml (60 mg) t.i.d. for 7 days.” NCT03837938
5

NCT01573663

NCT06907355

NCT01416480

NCT06252454

NCT07161180

Known as (s)-(-)-dropropizine ChEMBL registry synonym — accepted as the source's own label CHEMBL1288810
Known as Danka ChEMBL registry synonym — accepted as the source's own label CHEMBL1288810
Known as Dipropizine, (s)-isomer ChEMBL registry synonym — accepted as the source's own label CHEMBL1288810
Known as Dropropizine s-form ChEMBL registry synonym — accepted as the source's own label CHEMBL1288810
Known as L-dropropizine ChEMBL registry synonym — accepted as the source's own label CHEMBL1288810
Known as Levodropropizina ChEMBL registry synonym — accepted as the source's own label CHEMBL1288810
Known as Levopront Levopront® (levodropropizine) syrup 30 mg/5 ml 10 ml (60 mg) t.i.d. for 7 days.” NCT03837938
Known as Levotuss ClinicalTrials.gov intervention name — accepted as the source's own label NCT03489837
Known as Rapitux ChEMBL registry synonym — accepted as the source's own label CHEMBL1288810
Modality Small molecule CHEMBL1288810
Route Oral “Levodropropizine 60mg, PO, single dose” NCT01573663